冯颖青

• 1:广东省人民医院心内科

摘要(Abstract)：

<正>1肾动脉交感神经射频消融术(RDN)关于RDN,2013年欧洲心脏病学会(ESC)年会上有3个专场讨论。来自澳大利亚肾脏病实验室Schlaich教授介绍了RDN的病理生理基础;Henry Krum介绍了RDN的历程及HTN-1研究36个月的随访结果,欧洲RDN真实世界的研究;Michael B hm介绍了全球超过200个中心参与的GLOBAL SYMPLICITY RDN登记研究;德国教授Mahfound对RDN降压以外的进展进行了展望。与会者就下列问题展开讨论。

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 冯颖青

参考文献(References)：

• [1]Henry Krum,Neil Barman,Markus Schlaich,et al.Long-term follow-up of catheter-based renal sympathetic denervation for resistant hypertension confirms durable blood pressure reduction[J].JACC,2012,59(13):51-53.
• [2]Esler MD,Krum H,Sobotka PA,et al.Renal sympathetic denervation in patients with treatment-resistant hypertension(The SymplicityHTN-2 Trial):a randomised controlled trial[J].Lancet,2010,376(9756):1903-1909.
• [3]Kandzari DE,Bhatt DL,Sobotka PA,et al.Catheter-Based Renal Denervation for Resistant Hypertension:Rationale and Design of the SYMPLICITYHTN-3 Trial[J].Clinical cardiology,2012,35(9):528-535.
• [4]Hering D,Lambert EA,Marusic P,et al.Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension[J].Hypertension,2013,61(2):457-464.
• [5]ENCORD Committee.ENCORD Study[R].European Society of Cardiology Congress,Amsterdam,2013.
• [6]Zuern CS,Eick C,Rizas KD,et al.Impaired Cardiac Baroreflex Sensitivity Predicts Response to RenalSympathetic Denervation in Patients with Resistant Hypertension[J].J Am CollCardiol,2013[Epub ahead of print].
• [7]Kaltenbach B,Franke J,Bertog SC,et al.Renal sympathetic denervation as second-line therapy in mild resistant hypertension:a pilot study[J].Catheter Cardiovasc Interv,2013,81(2):335-339.
• [8]MahfoudF,SchalaichM,KindermannI,et al.Eeffect of renal sympathetic demervation on glucose metabolism in patients with resistanthypertension:APilotstudy[J].Circulation,2011,123(18):1940-1946.
• [9]Witkowski A,Prejbisz A,Florczak E,et al.Effects of renal sympathetic denervation on blood pressure,sleep apnea course,and glycemic control in patients with resistant hypertension and sleep apnea[J].Hypertension,2011,58(4):559-565.
• [10]Hering D,Mahfoud F,Walton AS,et al.Renal denervation in moderate to severe CKD[J].J Am SocNephrol,2012,23(7):1250-1257.
• [11]Davies JE,Manisty CH,Petraco R,et al.First-in-man safety evaluation of renal denervation for chronic systolic heart failure:Primary outcome from REACH-Pilot study[J].Int J Cardiol,2013,163(3):189-192.
• [12]Mancia G,Fagard R,Narkiewicz K,et al.2013ESH/ESCguidelines for the management of arterial hypertension:the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC)[J].Eur Heart J,2013,34(28):2159-2219.
• [13]Denardo SJ,Gong Y,Nichols WW,et al.Blood pressure and outcomes in very old hypertensive coronary artery disease patients:an INVEST substudy[J].Am J Med,2010,123(8):719-726.
• [14]Zanchetti A,Grassi G,Mancia G.When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered?A critical reappraisal[J].J Hypertens,2009,27(5):923-934.
• [15]Lewington S,Clarke R,Qizilbash N,et al.Age-specific relevance of usual blood pressure to vascular mortality:a meta-analysis of individual data for one million adults in 61prospective studies[J].Lancet,2002,360(9349):1903-1913.
• [16]Sundstr m J,Neovius M,Tynelius P,et al.Association of blood pressure in late adolescence with subsequent mortality:cohort study of Swedish male conscripts[J].BMJ,2011,342:d643.
• [17]ASCOT Steering Committee.Age-Stratified Analysis of Blood Pressure Responses[R].European Society of Cardiology Congress,Amsterdam,2013.
• [18]McCormack T,Krause T,O'Flynn N.Management of hypertension in adults in primary care:NICE guideline[J].Br J Gen Pract,2012,62(596):163-164.
• [19]Balkau B,Mhamdi L,Oppert JM.Physical activity and insulin sensitivity:the RISC study[J].Diabetes,2008,57(10):2613-2618.
• [20]Ferrannini E,Cushman WC.Diabetes and hypertension:the bad companions[J].Lancet,2012,380(9841):601-610.